1297392

Catalent Pharma Solutions, LLC — FEI 3007617094

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 17, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Philadelphia, PA (United States)